Efficient synthesis of novel colchicine-magnolol hybrids and evaluation of their inhibitory activity on key proteases of 2019-nCoV replication and acute lung injury

References

• Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE. 2022. Targeting and modulation of the natriuretic peptide system in Covid-19: A single or double-edged effect? Curr Protein Pept Sci.
   Web of Science ®Google Scholar
• Bahun M, Jukić M, Oblak D, Kranjc L, Bajc G, Butala M, Bozovičar K, Bratkovič T, Podlipnik Č, Poklar Ulrih N. 2022. Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols. Food Chem. 373(Pt B):131594.
   PubMedGoogle Scholar
• Ergul M, Bakar-Ates F. 2021. Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 73:105138.
   PubMed Web of Science ®Google Scholar
• Garazd YL, Garazd MM, Kartsev VG. 2015. Synthesis of colchicine C-10-amio-acid derivatives. Chem Nat Compd. 51(6):1138–1141.
   Web of Science ®Google Scholar
• Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, Zioga N, Kogias D, Natsi A-M, Pelekoudas C, et al. 2022. Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure. Clin Immunol. 238:109016.
   PubMed Web of Science ®Google Scholar
• Ghawanmeh AA, Al-Bajalan HM, Mackeen MM, Alali FQ, Chong KF. 2020. Recent developments on (–)-colchicine derivatives: synthesis and structure-activity relationship. Eur J Med Chem. 185:111788.
   PubMed Web of Science ®Google Scholar
• Gracheva IA, Shchegravina ES, Schmalz HG, Beletskaya IP, Fedorov AY. 2020. Colchicine alkaloids and synthetic analogues: current progress and perspectives. J Med Chem. 63(19):10618–10651.
   PubMed Web of Science ®Google Scholar
• Huczyński A, Rutkowski J, Popiel K, Maj E, Wietrzyk J, Stefańska J, Majcher U, Bartl F. 2015. Synthesis, antiprolifera-tive and antibacterial evaluation of C-ring modified colchicine analogues. Eur J Med Chem. 90:296–301.
   PubMed Web of Science ®Google Scholar
• Kato Y, Higashiyama A, Takaoka E, Nishikawa M, Ikushiro S. 2021. Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro. Adv Redox Res. 3:100021.
   PubMedGoogle Scholar
• Kneller DW, Li H, Phillips G, Weiss KL, Zhang Q, Arnould MA, Jonsson CB, Surendranathan S, Parvathareddy J, Blakeley MP, et al. 2022. Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease. Nat Commun. 13(1):2268.,.
   PubMed Web of Science ®Google Scholar
• Korkmaz B, Lesner A, Marchand-Adam S, Moss C, Jenne DE. 2020. Lung protection by Cathepsin C inhibition: a new hope for COVID-19 and ARDS? J Med Chem. 63(22):13258–13265.
   PubMed Web of Science ®Google Scholar
• Kuzikov M, Costanzi E, Reinshagen J, Esposito F, Vangeel L, Wolf M, Ellinger B, Claussen C, Geisslinger G, Corona A, et al. 2021. Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in vitro repurposing screen. ACS Pharmacol Transl Sci. 4(3):1096–1110.
   PubMedGoogle Scholar
• Landoni G, Piemonti L, Monforte AD, Grossi P, Zangrillo A, Bucci E, Allegretti M, Goisis G, Gavioli EM, Patel N, et al. 2022. A multicenter Phase 2 randomized controlled study on the efficacy and safety of reparixin in the treatment of hospitalized patients with COVID-19 Pneumonia. Infect Dis Ther.
   PubMed Web of Science ®Google Scholar
• Lin ZY, Wu CC, Chuang YH, Chuang WL. 2013. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma. Life Sci. 93(8):323–328.
   PubMed Web of Science ®Google Scholar
• Liu H, Iketani S, Zask A. 2022. Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL pro-tease for treatment of COVID-19. Nat Commun. 13:1891.
   PubMed Web of Science ®Google Scholar
• Mao SH, Feng DD, Wang X, Zhi YH, Lei S, Xing X, Jiang RL, Wu JN. 2021. Magnolol protects against acute gas-trointestinal injury in sepsis by down-regulating regulated on activation, normal T-cell expressed and secreted. World J Clin Cases. 9(34):10451–10463.
   PubMed Web of Science ®Google Scholar
• McKenzie BJ, Wechalekar MD, Johnston RV, Schlesinger N, Buchbinder R. 2021. Colchicine for acute gout. Cochrane Database Syst Rev. 8:CD006190.
   PubMedGoogle Scholar
• Mohiuddin CA, Kamal A, Abbas KU, Talukder S, Karim MR, Ali MA, Nuruzzaman M, Li Y, He S. 2022. Efficacy and outcome of remdesivir and tocilizumab combination against dexamethasone for the treatment of severe COVID-19: A Randomized Controlled Trial. Front Pharmacol. 13:690726.
   PubMed Web of Science ®Google Scholar
• Muhammad W, Zhu J, Zhai Z, et al. 2022. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment. Acta Biomater.
   Web of Science ®Google Scholar
• Nawabi AQ, Hassan W, Chen L, Shaikh N, Abbas K, Zehra FT. 2022. Is colchicine a new game-changer in patients with acute coronary syndrome? Cureus. 14(3):e22874.
   PubMed Web of Science ®Google Scholar
• Shapira T, Monreal IA, Dion SP, Buchholz DW, Imbiakha B, Olmstead AD, Jager M, Désilets A, Gao G, Martins M, et al. 2022. A TMPRSS2 in-hibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature. 605(7909):340–348.
   PubMed Web of Science ®Google Scholar
• Tanikawa T, Hayashi T, Suzuki R, Kitamura M, Inoue Y. 2022. Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection. J Tradit Complement Med. 12(1):69–72.
   PubMedGoogle Scholar
• Tao C, Chen J, Huang X, Chen Z, Li X, Li Y, Xu Y, Ma M, Wu Z. 2020. CT1-3, a novel magnolol-sulforaphane hybrid suppresses tumorigenesis through inducing mitochondria-mediated apoptosis and inhibiting epithelial mesenchymal tran-sition. Eur J Med Chem. 199:112441.
   PubMed Web of Science ®Google Scholar
• Ting CT, Chen BS. 2022. Repurposing multiple-molecule drugs for COVID-19-associated acute respiratory distress syn-drome and non-viral acute respiratory distress syndrome via a systems biology approach and a DNN-DTI model based on five drug design specifications. IJMS. 23(7):3649.
   Google Scholar
• Yasmin F, Najeeb H, Moeed A, Hassan W, Khatri M, Asghar MS, Naveed AK, Ullah W, Surani S. 2022. Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials. PLoS One. 17(4):e0266245.
   PubMed Web of Science ®Google Scholar
• Yu CP, Li PY, Chen SY, Lin SP, Hou YC. 2021. Magnolol and honokiol inhibited the function and expression of BCRP with mechanism exploration. Molecules. 26(23):7390.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhu Y, Liu X, et al. 2022. Structural basis for replicase polyprotein cleavage and substrate speci-ficity of main protease from SARS-CoV-2. PNAS. 119:e2117142119.
   Google Scholar